Linden LLC, operating as Linden Capital Partners, is a Chicago-based private equity firm founded in 2004 that focuses. See sector focus and contact routes.
Linden LLC, operating as Linden Capital Partners, is a Chicago-based private equity firm founded in 2004 that focuses exclusively on leveraged investments in middle-market healthcare and life science companies. The firm’s investment thesis targets buyouts, management buyouts, growth equity, recapitalizations, and corporate divestitures within healthcare services, life sciences, and medical devices. While specific check sizes and lead/follow behavior are not publicly detailed, the firm prefers “more substantial investments” and pursues acquisition opportunities across the broader healthcare industry including products and distribution. Notable portfolio companies include Regenity Biosciences, a medical device company, and the firm previously acquired Ranir/DCP Corporation. Linden distinguishes itself through a dedicated Value Creation Program and collaborative partnerships with management teams, emphasizing sector concentration rather than geographic diversification. The firm manages approximately $13.9 billion in assets under management as of late 2025 and received a minority investment from Blue Owl’s GP Strategic Capital platform and Lunate Capital in 2024[8
Details on this firm come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist comparable investors.
Investors like Linden LLC, operating as Linden Capital Partners · Full investor directory · Investor access · Company funding database